What is Medocity?
Medocity offers a patient-centric mobile solution designed to integrate disease-specific care into a unified platform accessible via web and application-based devices. The company's comprehensive disease platform addresses the needs of both patients and healthcare providers across critical areas such as oncology, congestive heart failure, chronic obstructive pulmonary disease, senior living care, and home health services. Headquartered in Parsippany, New Jersey, Medocity aims to streamline care coordination and enhance patient engagement through its technology.
How much funding has Medocity raised?
Medocity has raised a total of $4.9M across 6 funding rounds:
Private Equity
$800K
Private Equity
$1.6M
Private Equity
$650K
Angel/Seed
$1.1M
Debt
$675K
Debt
$150K
Private Equity (2013): $800K, investors not publicly disclosed
Private Equity (2014): $1.6M, investors not publicly disclosed
Private Equity (2015): $650K, investors not publicly disclosed
Angel/Seed (2016): $1.1M, investors not publicly disclosed
Debt (2016): $675K, investors not publicly disclosed
Debt (2020): $150K with participation from PPP
What's next for Medocity?
The recent major strategic investment signifies Medocity's transition into a more mature enterprise-level stage, likely focusing on scaling its operations, expanding market reach, and further developing its innovative patient care platform. This capital infusion is expected to fuel strategic initiatives, potentially including enhanced feature development, broader healthcare system integrations, and increased marketing efforts to solidify its position in the competitive health tech landscape. The company's focus on critical care areas suggests a strategy aimed at addressing significant unmet needs within the healthcare ecosystem.
See full Medocity company page
